List view / Grid view
2 March 2017 | By Niamh Marriott, Digital Editor
The European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for Abbvie’s shorter, eight-week treatment of Viekirax (ombitasvir/paritaprevir/ritonavir tablets) + Exviera (dasabuvir tablets) as an option for previously untreated adult patients with geotype 1b chronic hepatitis C virus (HCV)…
2 March 2017 | By Niamh Marriott, Digital Editor
NICE has published draft guidance which does not recommend Keytruda, also known as pembrolizumab, for untreated PD-L1-positive metastatic lung cancer...
1 March 2017 | By Niamh Marriott, Digital Editor
European Pharmaceutical Review was invited to the grand opening Richmond Pharmacology's new clinical research facility in central London.
28 February 2017 | By Niamh Marriott, Digital Editor
If approved by the European Commission, daratumumab can be used for the treatment of adult patients with multiple myeloma...
27 February 2017 | By Niamh Marriott, Digital Editor
The EMA approved Novartis’ Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with non-small cell lung cancer...
23 February 2017 | By Niamh Marriott, Digital Editor
AstraZeneca announced positive results from its Phase III trial comparing Lynparza to chemotherapy, to treat HER2-negative metastatic breast cancer...
23 February 2017 | By Niamh Marriott, Digital Editor
The European Commission has approved Truxima (biosimilar rituximab) for all indications of reference rituximab in the European Union.
The use of industrial sieving equipment in pharmaceutical manufacturing is critical to ensure product quality and integrity. To keep up with growing product demand, most pharmaceutical manufacturers must also improve productivity while protecting the health and safety of operators.
22 February 2017 | By Niamh Marriott, Digital Editor
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical study of its lead product candidate, ATX-MS-1467, for the treatment of patients with multiple sclerosis. The Phase IIa, open-label, one arm study evaluated the effects of…
21 February 2017 | By Niamh Marriott, Digital Editor
Researchers at MIT have found a new way of using mid-infrared lasers to turn regions of molecules into glowing filaments of electrically charged gas...
21 February 2017 | By Niamh Marriott, Digital Editor
VTT Technical Research Centre of Finland has developed a miniature gas sensor that can be connected to mobile devices.
21 February 2017 | By Niamh Marriott, Digital Editor
A new study has tied the World Trade Centre (WTC) site with paresthesias, a nerve-related issue causing burning or prickling sensations...
20 February 2017 | By Johanna Laiho-Kauranne, Director of Statistics, Luke
Johanna Laiho-Kauranne examines the 17 UN sustainable development goals that have been implemented for monitoring sustainability development...
20 February 2017 | By Niamh Marriott, Digital Editor
Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...
20 February 2017 | By Niamh Marriott, Digital Editor
Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.
